Senti Biosciences Holdings IncSNTI
Price$0.26

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $55KTTM through 30 Jun 2026
Net Income -$49.6MTTM through 30 Jun 2026
Free Cash Flow -$44.6MTTM through 30 Jun 2026

Margins

Current
Gross Margin0.0%
Operating Margin-99,434.5%
Net Margin-90,116.4%

Returns

N/A (negative equity)ROE
-134.8%ROA

Balance Sheet Health

Debt / EquityN/A (negative equity)
Current Ratio0.83x
Net Debt$10.2M
Cash & Equivalents$6.5M

Quality Metrics

Altman Z-Score-21.27
Piotroski F-Score1 / 9
FCF Margin-81,069.1%
Earnings-Beat Rate50.0%

Multi-Year Trend

Revenue
'21'22'23'24'25
FY2025: $22K
Diluted EPS-$1.69TTM
'21'22'23'24'25
FY2025: $-2.73

Dividend

No dividend

Capital Allocation

Capex Intensity11,885.5%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.